Gadoquatrane, a contrast agent Bayer is developing for use in MRI scans, like those done in MS, uses 60% less gadolinium and ...
Treating patients with aspirin after completion of standard adjuvant therapy for colorectal cancer failed to significantly ...
The pharmaceutical company’s latest partnership with Incremental and Skai drove a 32% boost in iROI, delivering nearly a ...
The ARIES-HM3 substudy may help persuade implanters who are less well-versed in the circulatory changes an LVAD affords.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback